No. The boss man covered this like a year ago and it’s clear that a range of treatments would still be needed regardless of vaccines. It’s more true now than ever with the vaccines proven to be leaky, reduced efficacy over time and breakthrough infections. Not to mention new strains.
There is a market there and it will not go away, we just need this additional trial done to validate the data from the first trial.
let’s see what happens.
No. The boss man covered this like a year ago and it’s clear...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3730649 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |